Different concepts for creating antibacterial yet biocompatible surfaces: Adding bactericidal element, grafting therapeutic agent through COOH plasma polymer and their combination by Permyakova, Elizaveta et al.
1
Different concepts for creating antibacterial yet biocompatible surfaces:
adding bactericidal element, grafting therapeutic agent through COOH
plasma polymer and their combination
Elizaveta S. Permyakova1, Anton M. Manakhov1*, Philipp V. Kiryukhantsev-Korneev1,
Alexander N. Sheveyko1, Kristina Y. Gudz1, Andrey M. Kovalskii1, Josef Pol ak2,3, Irina Y.
Zhitnyak4, Natalia A. Gloushankova4 , Ivan A. Dyatlov5 , Sergei G. Ignatov5,6, Sergey Ershov7,
and Dmitry V. Shtansky1
1 National University of Science and Technology "MISIS", Leninsky prospect 4, Moscow,
119049, Russia
2 CEITEC—Central European Institute of Technology, Brno University of Technology,
Purky ova 123, Brno, Czech Republic
3 Institute of Physical Engineering, Brno University of Technology, Technicka 2896/2, 616 69
Brno, Czech Republic
4 N.N. Blokhin Medical Research Center of Oncology, Kashirskoe shosse 24, Moscow 115478,
Russia;
5 State Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow
Region 142279, Russia
6 Federal Autonomous Scientific institution "Eastern Center for State Planning" (FANU
"Vostokgosplan")
7 Laboratory for the Physics of Advanced Materials (LPM), Department of Physics and
Materials Science, University of Luxembourg, L-1511 Luxembourg
* Correspondence: ant-manahov@ya.ru; Tel.: +7-915-8494059
Abstract
Antibacterial coatings have become a rapidly developing field of research, strongly stimulated by
the increasing urgency of identifying alternatives to the traditional administration of antibiotics.
Such coatings can be deposited onto implants and other medical devices and prevent the
inflammations caused by hospital-acquired infections. Nevertheless, the design of antibacterial
yet biocompatible and bioactive surfaces is a challenge that biological community has faced for
many years but the “materials of dream” have not yet been developed. In this work, the
biocompatible yet antibacterial multi-layered films were prepared by a combination of
magnetron sputtering (TiCaPCON film), ion implantation (Ag-doped TiCaPCON film), plasma
polymerization (COOH layer), and final immobilization of gentamicin (GM) and heparin (Hepa)
molecules. The layer chemistry was thoroughly investigated by means of FTIR and X-ray
photoelectron spectroscopies. It was found that the immobilization of therapeutic components
occurs throughout the entire thickness of the plasma-deposited COOH layer. The influence of
each type of bactericide (Ag+ ions, GM, and Hepa) on antibacterial activity and cell proliferation
was analyzed. Our films were cytocompatible and demonstrated superior bactericidal efficiency
toward antibiotic-resistant bacterial E. coli K261 strain. Increased toxicity while using the
combination of Ag nanoparticles and COOH plasma polymer is discussed.
Introduction
Antibacterial coatings are rapidly emerging as a primary component of the global mitigation
strategy of bacterial pathogens, because this is highly efficient approach for prevention of the so-
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called nosocomial (hospital-acquired) infections. Such infections are considered as a major
health challenge in healthcare units worldwide [1].
There are three major strategies for designing antibacterial coatings based on infection
suppression mechanisms: antibacterial agent release, contact-killing, and anti-adhesion/bacteria-
repelling [2]. The agent release method is based on the leaching of therapeutic agent (bactericide
ions or drugs) leading to the bacterial killing [3]. The contact killing method involves the killing
of the bacteria upon their contact with a surface due to the damages induced by specific
topography, surface local currents, or charge distributions [4,5] . The anti-adhesion/bacteria-
repelling methods are based either on the grafting of anti-adhesion biomolecules or on the
modulation of surface superhydrophilicity [2,6].
The main limitations of the existing strategies for the development of antibacterial coatings
include (i) the complexity of control of the bactericide agent release, (ii) the relatively short-term
antibacterial effect, and (iii) the possible toxicity of bactericidal ions or antibiotics. Obviously, a
combination of several strategies modulating the antibacterial effect can be useful due to the
synergetic effect of several antibacterial actions. The design of antibacterial yet biocompatible
and bioactive surfaces is a challenge that biological community has faced for many years but the
“materials of dream” have not yet been developed [7]. Although the bulk properties of materials
in healthcare applications have been more or less fully optimized, the implant-related microbial
infections remain a serious problem in reconstructive surgery [8]. Surface engineering is an
effective tool to impart desirable chemical, biological, and mechanical characteristics to a
surface without compromising its bulk properties [9,10]. The modification of chemistry and
morphology of an implant surface may significantly affect both antibacterial activity and
bioactivity [11–13].
In order to improve the bioactivity of specific materials (e.g. Ti surface in the context of implant
devices), a composite Ti-Ca-P-C-O-N film could be very beneficial. As shown earlier, such a
layer is highly bioactive [14,15]. In order to endow material with antibacterial effect, the
implantation of bactericidal elements (Cu, Ag, etc.) or drug loading were tested [16,17].
However, these approaches only led to a relatively short-term antibacterial effect, whereas longer
bacterial protection is required. A long-term controlled release is of high demand in case of
complications or reoperation when there is an inflammatory process in the surrounding tissues
[18]. Up to date, the design of coatings that can ensure the release of the required level of
bactericidal component sufficient to kill bacteria, but safe for eukaryotes, remains a significant
challenge.
In the current work, the bioactivity of TiCaPCON surface was further enhanced by deposition of
a thin layer of carboxylic plasma polymer using CO2/C2H4 plasma polymerization carried out in
the same vacuum chamber in which the TiCaPCON layer was deposited. The deposition
experiments were performed at a low-pressure of 2-4 Pa using Ar/C2H4/CO2 radio frequency
plasma. The resulting TiCaPCON-COOH samples were used as smart platforms for further
surface functionalization to impart bactericidal characteristics. The utilization of Ar/CO2/C2H4
plasma will provide a stable layer containing carboxylic groups with a good adhesion to the
TiCaPCON layer. The COOH groups and the negatively charged surface are expected to provide
the growth of hydroxyapatite layer. Moreover, the COOH groups could also serve as active cites
for a strong covalent bonding of different active molecules included in the antibiotics [19,20].
The aim of this work is to study the biocompatibility and antibacterial activity of a
multicomponent coating system consisting of an Ag-implanted TiCaPCON layer and a top
COOH plasma-deposited layer with covalently bonded gentamicin and heparin. Gentamicin was
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chosen because it has amino-containing molecules for covalent immobilization with COOH
plasma polymer and is widely used for the treatment of bone infections caused by gram-positive
and gram-negative bacteria. The bactericide grafting strategy is based on the immobilization of
gentamicin by the COOH groups of plasma polymer (deposited on the surface of TiCaPCON
layer) via the EDC coupling chemistry. Subsequently, the antiadhesive heparin molecules are
immobilized on the gentamicin surface through the ionic bonds formed between the positively
charged amine groups of gentamicin and the negatively charged COOH groups of heparin.
With such a coating design, gentamicin is covalently bound with the COOH groups of the
plasma polymer and the ionically bound with heparin. Due to the different types of chemical
bonds, gentamicin is expected to be released rapidly at the beginning of dissolution (due to
weaker ionic bonding) and then more slowly (due to stronger covalent bonding).
Simultaneously, heparin will provide additional antibacterial effect and stimulate cell viability.
2 Materials and Methods
2.1 Deposition of a TiCaPCON layer and Ag implantation
The deposition experiments were performed using a UVN-2M (Russia) vacuum set-up equipped with
magnetron sputtering system, ion source, and MEVVA-type ion implanter. Typical rig scheme is
presented in the [21] . The TiCaPCON films were deposited by magnetron sputtering of a composite TiC-
CaO-Ti3POx target in a gaseous mixture of Ar and 15% N2. The applied magnetron current was 2 A, the
magnetron voltage was ~ 450 V, and the bias voltage was controlled at -50 V (samples denoted as
TiCaPCON throughout the text). The target to substrate distance was fixed to 120 mm. A silver ions were
sputtered using an MEVVA-type implanter additional Ar ion source operating with the acceleration
voltage of 20 kV and the current of 20 mA (samples hereafter denoted as TiCaPCON-Ag) [22] . The
depth of implantation is less than 30 nm and silver tend to form nanodroplets and shallow depth as
showed before [5].
2.2 Deposition of a COOH plasma layer
The COOH plasma polymer layer was deposited onto the surface of pristine, TiCaPCON-, and
TiCaPCON-Ag-coated Si wafers. The polymer layer deposition was carried out using second
UVN-2M vacuum system equipped with the radio frequency (RF) source. The residual pressure
in the vacuum chamber was below 10-3 Pa. The plasma was ignited using RF power supply Cito
1310-ACNA-N37A-FF (Comet) connected to the RFPG-128 disk generator (Beams & Plasmas)
installed in the vacuum chamber. The pulse period, duty cycle, and the RF power were set to
2.033 μs, 5%, and 500 W, respectively. The operating frequency was 13.56 MHz. CO2
(99.995%), Ar (99.998%), and C2H4 (99.95%) were fed into the vacuum chamber. The gas flow
rates were set to 50 (Ar), 16.2 (CO2), and 6.2 (C2H4) sccm and controlled using a Multi Gas
Contoller647C (MKS). The pressure in vacuum chamber was measured by VMB-14 unit
(Tokamak) and D395-90-000 BOC (Edwards) controllers. The distance between the RF-
electrode and the substrate was set to 8 cm. The deposition time was 15 min during which ~100
nm thick plasma coating was formed.
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2.3 Gentamicin and heparin loading
Gentamicin (GM) was covalently bonded to the COOH plasma polymer layer by immersion the
samples into the 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) (98% Sigma Aldrich)
water solution (2 mg/ml) for 15 min, followed by washing with the phosphate buffer saline
(PBS), air exposure at room temperature for 120 min, and the final cleaning with de-ionized
water. The samples prepared according to this procedure (Fig.1 a,b) hereafter denoted as –
COOH-GM.
In order to immobilize heparin, –COOH-GM samples were immersed into 2% heparin water
solution for 120 min and then washed with de-ionized water (samples denoted as –COOH-GM-
Hepa). The expected bonding is depicted in Fig. 1c. The final GM loading was performed by
keeping –COOH-GM-Hepa samples in 2% water solution of GM for 120 min followed by the
washing with de-ionized water. The expected bonding is depicted in Fig. 1d. These samples are
designated as –COOH-GM-Hepa-GM.
Fig.1 Schematic representation of the GM and heparin immobilization: attachment of GM to the
plasma-deposited COOH layer (a), conjugation of heparin with GM-COOH complex (b),
attachment of the next GM layer (c), formation of COOH-GM-Hepa-GM multilayer (d).
2.4 Characterization of the layer chemistry and morphology
The TiCaPCON film was investigated using a JSM-7600F Schottky field emission scanning
electron microscope (JEOL Ltd.) equipped with an energy-dispersive X-ray (EDX) X-Max 80
Premium detector (Oxford Instruments) operated at 15 kV. To compensate for the surface
charging, the samples were coated with a ∼5 nm thick Pt layer.
AFM analysis of samples was performed on an Integra Spectra microscope (NT-MDT) using
silicon-nitride NSG10 scanning probes (NT-MDT) with a tip radius of 8 ± 2.1 nm.
The chemical composition of surfaces was determined by the X-ray photoelectron spectroscopy
(XPS) using an Axis Supra spectrometer (Kratos Analytical). The maximum lateral dimension of
the analyzed area was 0.7 mm. The spectra were fitted using the CasaXPS software after
subtracting the Shirley-type background. The binding energies (BE) values for all carbon,
titanium, and nitrogen environments were taken from the literature [5,19,23]. The BE scale was
calibrated by shifting the CHx component to 285.0 eV. XPS depth profiling was performed using
a) b) c) d)
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Ar500+ cluster gun with the energy of 10 keV. The size of the crater was 2 by 2 mm. The
etching was done in 18 steps (each step was 30s).
2.5 Bactericide release
The concentration of Ag ions released from the sample surfaces into phosphate-buffered
saline (PBS, pH 7.4) was studied by inductively coupled plasma mass spectroscopy (ICP-MS)
using a X-Series II instrument (Thermo Fisher Scientific). The samples (1 × 1 cm2) were
immersed in flasks filled with 20 mL of PBS and kept at room temperature. Then 1.5 mL
aliquots were collected after 1, 3, 8 h and further after 1, 3, 5 and 7 days to analyze the
concentration of released ions. The gentamicin/heparin-modified samples with and without Ag
were immersed in flasks filled with 20 mL of PBS (pH 7.4) at room temperature. To analyze
antibiotic concentration, 500 μL of each supernatant was collected after 1, 3, 8 h and further after
1, 3, 5 and 7 days. After each sampling, the solution volume was increased to the initial one by
adding 500 μL of fresh PBS. The antibiotic release kinetics was studied by means of an UV
spectrophotometer (Ocean Optics). Measurements were performed in the wavelength range of
0−1000 nm. The maximum absorption intensities for gentamicin and heparin were 224 and 256
nm, respectively, which were used for further quantification. Curve of samples containing both
therapeutic agents were fitted by Multiple Peak Fit Tool (Origin Pro 2018). To plot a calibration
curve, absorbance of antibiotic solutions with concentrations in the range of 0.005−4 mg/ mL
was measured. The antibiotic concentration released into PBS over time was evaluated by
comparing with the calibration curve. Experiments on the drug release were carried out in
triplicate for each antibiotic type.
2.6 Analysis of osteblastic cell proliferation
MC3T3-E1 cells (104 cells/ml) were seeded on the surface of samples placed into 12-well plates
containing 2 ml of DMEM/F12 culture medium per well (a 1:1 mixture of Dulbecco’s Modified
Essential Medium (DMEM) and Ham’s F-12 Medium) (Gibco) with 10% of fetal calf serum
(РАА). The cultures were grown in a humidified atmosphere with 5% of CO2 at 37 oС for 24 h.
After 1, 3, 5, and 7 days of incubation, cells were fixed with 3.7% paraformaldehyde and stained
with 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI) (Sigma). The number of cells in
the field was determined with an Zeiss Axioplan microscope (Zeiss, Germany) equipped with a
×40 objective. The mean values of thirty examined fields for each tested plate were calculated.
All data reported as MEAN ± SEM. The statistics was analyzed according to Kruskal-Wallis
criteria.
2.7 Antibacterial activity
The antibacterial activity of samples was evaluated against clinically isolated antibiotic-resistant
bacterial E. coli K261 strain. The bacterial cells were cultivated either in Luria-Bertani (LB)
broth medium or onto solid LB-agar. The LB-broth medium consisted of 10 g of bacto-trypton, 5
g of yeast extract, and 5 g of NaCl in 1 L of distilled water. The LB-agar contained LB-broth
medium (prepared as described above) and 18 g of agar in 1 L of distilled water. For quantitative
evaluation, the samples were placed in the sterile 12-well culture plate (Corning Costar) with 0.5
mL of normal saline solution (0.9% saline, hereafter denoted as NSS) and incubated in a
thermostat at 37 °C. Then, 0.03 mL of overnight bacterial culture was added to the plates in such
a way that the tested samples were fully immersed in the bacterial suspension. One sample-free
well was used as a control. After 3 and 24 h, the concentration of bacterial colony forming units
(CFUs) was determined by decimal dilution in 0.3 mL of NSS. One hundred µL of decimal
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diluted suspension was dispersed onto a solid nutrient agar in sterile Petri dishes. The number of
surviving CFUs in each Petri dish was counted after incubation at 37oC for 3 and 24 h. The
values of CFUs for three Petri dishes with the same samples were averaged.
3 Results and discussion
3.1 Morphology of deposited films.
Figure 2 compares the surface morphologies of Si-(TiCaPCON)-COOH, Si-(TiCaPCON)-
COOH-GM, Si-(TiCaPCON)-COOH-GM-Hepa, and Si-(TiCaPCON)-COOH-GM-Hepa-GM
samples. Without a polymer layer, the TiCaPCON surface is covered with 3D islands with lateral
size in the range of 15-35 nm (Fig. 2a). After GM deposition, the cauliflower-like homogenous
surface morphology has not changed (Fig. 2b). Heparin immobilization led to the appearance of
smaller surface topographical features, apparently as a result of a new nucleation and growth
(Fig. 2c). Grafting of the second layer of gentamicin led to the disappearance of small surface
features; an average lateral size of 3D surface hills was approximately 50 nm (Fig. 2d). The
morphology of our samples was also confirmed by AFM measurements (see the Supporting
Inormation)
3.2 Elemental compositions of TiCaPCON and TiCaPCON-Ag layers
The elemental compositions of the TiCaPCON and TiCaPCON-Ag layers, as determined by XPS
analysis, are given in Table 1. After Ag+ ion implantation, in addition to the presence of Ag (~2
at.%), the titanium and oxygen concentrations were observed to significantly increase at the
expense of carbon and nitrogen.
Table 1 Sample elemental compositions as derived from the XPS analysis.
Concentration, at.%
Sample Ti C O N Ag Ca S
Si-TiCaPCON 9.7 58.4 22.0 8.7 0.0 1.3 0.0
Si-TiCaPCON-Ag 14.0 37.4 42.5 3.1 2.0 1.0 0.0
Si-TiCaPCON-COOH 0.0 77.9 22.1 0.0 0.0 0.0 0.0
Si-TiCaPCON-Ag-COOH 0.0 72.4 23.5 3.6 0.5 0.0 0.0
Si-TiCaPCON-(Ag)-COOH-GM 0.0 75.1 19.6 5.0 0.0 0.0 0.3
Si-TiCaPCON-(Ag)-COOH-GM-Hepa 0.0 74.4 19.7 5.4 0.0 0.0 0.5
Si-TiCaPCON-(Ag)-COOH-GM-Hepa-GM 0.0 70.4 23.3 5.8 0.0 0.0 0.5
In order to thoroughly analyze the functional composition of the TiCaPCON and TiCaPCON-Ag
surfaces, the C1s, Ti2p, and N1s signals were fitted using CasaXPS software (Fig. 3).
The XPS Ti2p signal of the TiCaPCON layer is shown in Fig. 3a. Due to the better-resolved Ti
2p 3/2 signal as compared to Ti 2p ½ counterpart, the first peak was used for further XPS
analysis. The XPS Ti2p 3/2 peak was fitted using three components (Fig. 3a): TiC (BE=455.3
eV, FWHM=1.2 eV), TiN (BE=456.6 eV FWHM=1.8 eV), and TiO2 (BE=458.5 eV,
FWHM=1.6 eV), indicating the presence of carbide, nitride, and oxide states on the TiCaPCON
surface. The fitting of C1s and N1s spectra also confirmed the presence of nitride and carbide
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(Fig 3b,c). The C1s peak was fitted by the sum of four components: hydrocarbons titanium
carbide Ti-C (BE=282.5 eV), hydrocarbons CHx (BE=285 eV), ether C-O group (BE=286.5 eV),
and carbon doubly bonded to oxygen C=O (BE=288.0 eV). For all four components, the full
width at the half maximum (FWHM) was set to 1.6±0.1 eV. The N1s signal was fitted with a
sum of three components: Ti-N (BE=397.1 eV), C-N (BE=399.2 eV), and NH3+ (BE=401.2 eV).
The XPS spectra of the TiCaPCON-Ag layer were significantly different. First, the Ti2p signal
revealed only one type of the environment, i.e. titanium dioxide (Fig. 3d). The absence of
titanium carbide was also supported by the C1s curve fitting (Fig. 3e). In addition, the N1s signal
showed no nitride peak (see Supporting Information, Figure S1). A single asymmetric Ag 3d 5/2
maximum centered at 368.2 eV indicated that Ag is in a metallic state (Fig. 3i).
The deposition of COOH plasma layer on both the TiCaPCON and TiCaPCON-Ag films
resulted in very similar surfaces. However, certain differences between the XPS spectra of
TiCaPCON-COOH (Fig. 4a) and TiCaPCON-Ag-COOH samples (Fig. 3h) can be noted.
Although for both surfaces no Ti was observed (the XPS wide scan of this sample presented in
Supporting Information, Fig. S2), the TiCaPCON-Ag-COOH sample displays a XPS Ag3d peak
(0.5 at.%) indicating that not all Ag nanoparticles are covered by the COOH plasma layer. The
Ag state remained the same as for the TiCaPCON-Ag sample, i.e. metallic nature (Fig. 3i). Thus,
in addition to the active COOH groups designed for covalent attachment of a therapeutic agent,
the presence of silver on the TiCaPCON-Ag-COOH surface offers an additional advantage in
terms of antibacterial properties.
Furthermore, the TiCaPCON-Ag-COOH film contained small amount of nitrogen (3.6 at.%) on
its surface. The N1s signal analysis (see Fig. S1, Supporting information) revealed that nitrogen
is in the amide environment (N-C=O). Note, however, that as follows from Fig. 3g,h, carbon to
oxygen bonds form the basis of COOH layer.
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Fig. 2 SEM images of Si-TiCaPCON-COOH (a), Si-TiCaPCON-COOH-GM (b), Si-TiCaPCON-
COOH-GM-Hepa (c), and Si-TiCaPCON-COOH-GM-Hepa-GM (d) samples.
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Fig.3 XPS spectra and their curve fitting for TiCaPCON (a-c), TiCaPCON-Ag (d-f), and
TiCaPCON-Ag-COOH films (g-i). Ti2p (a,d), C1s (b,e,h), N1s (c), Ag3d (f,i) and O1s (g).
3.3 Gentamicin and heparin immobilization
The immobilization of GM, heparin as well as the final loading of GM on the top of
heparin layer led to minor changes of the TiCaPCON-COOH morphology (Fig 2 b,c,d). It was
observed that the size of agglomerates became larger after each successive treatment step, this
being particularly noticeable after the final step (TiCaPCON-COOH-GM-Hepa-GM).
As noted above, the surface sensitive XPS technique reveals little difference in surface
chemistry of the TiCaPCON-COOH and (TiCaPCON-Ag)-COOH samples. After therapeutic
agent immobilization, no difference in surface composition between the Ag-doped and Ag-free
samples was observed. Therefore, the XPS results only for Ag-implanted samples after
gentamicin and heparin immobilization are presented below. For FT-IR spectroscopy analysis, a
simple Si-COOH system, both before and after GM and Hepa immobilization was used.
The C1s signals of the TiCaPCON-COOH, (TiCaPCON-Ag)-COOH-GM, (TiCaPCON-
Ag)-COOH-GM-Hepa, and (TiCaPCON-Ag)-COOH-GM-Hepa-GM samples were fitted with a
sum of four peaks: CHx (BE=285.0 eV), C-N/C-O (BE=286.4±0.1 eV eV), C=O/N-C=O
(BE=288.0±0.1 eV), and C(O)O (BE=289.1 ±0.05 eV eV). The FWHM value for all components
was set to 1.6±0.15 eV. As can be seen in Fig 4 (left column), the difference in carbon
environment between four samples is very small. In contrast, nitrogen signal can be used as a
fingerprint of the successful GM immobilization. As shown in Table 1 and Fig. 4 (right column),
no nitrogen was determined before the GM immobilization, whereas the TiCaPCON-COOH-GM
surface exhibited [N]=5.0 at.%. The XPS N1s peak was fitted with the sum of two well-known
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components: the amide environement (N-C=O, BE=399.9 eV) and the protonated amines (NH3+,
BE=401.4 eV. The formation of the amide bonds (N-C=O) is also consistent with the
appearance of peak around 1626 cm-1 in the corresponding FT-IR spectrum of the Si-COOH-GM
sample (Fig. 5). Thus, both the XPS and FT-IR spectroscopy results confirm the successful
immobilization of GM on the TiCaPCON-COOH surface (Fig. 1a).
The successful immobilization of heparin is supported by a small increase in the sulfur
content (in the sulfate form) on the sample surface as well as by a change in nitrogen
environment, namely by a decrease of the protonated amines component (Fig. 4f). FT-IR
analysis also revealed significant changes in the surface chemistry of the Si-COOH-GM-Hepa
sample as compared to its Hepa-free counterpart (Si-COOH-GM). The intensity of CH2 (~1450
cm-1) and SO42- (1045 cm-1) peaks increased and an additional N-H bending peak of the amide
bond (1575 cm-1) appeared. Thus, compared with previous studies [24], our results are more
convincing evidence of the attachment of heparin to the active sites of gentamicin.
The loading of GM into the TiCaPCON-COOH-GM-Hepa film led to further changes in
the N1s spectrum such as the appearance of a new component corresponding to the non-
protonated amines (curve fitting in Fig. 4h). The FT-IR analysis of the Si-COOH-GM-Hepa-GM
sample revealed a minor increase in the intensity of the N-H bending and C-N stretching peaks
suggesting that only a small amount of GM was grafted. Indeed, the ionic bonding of positively
charged gentamicin onto negatively charged heparin is significantly less efficient compared to
the covalent bonding of gentamicin onto COOH groups, because ionic bonding is weaker and led
to lower density of grafted GM molecules. As a result, the additional loading with GM occurs
only at the top heparin surface and thus is only detected by surface sensitive XPS analysis.
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Fig.4 XPS spectra and their curve-fitting for COOH- (a,b), COOH-GM- (c,d), COOH-GM-
Hepa- (e,f), and COOH-GM-Hepa-GM-functionalized surfaces. C1s (a,c,e,g) and N1s (b,d,f,h).
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Fig.5 Full-range FT-IR spectra of the Si-COOH, Si-COOH-GM, Si-COOH-GM-Hepa, and Si-
COOH-Hepa-GM samples (a) and their zoomed view in the range of 2000 - 900 cm-1 (b).
3.4 Depth profile of Si-COOH-GM-Hepa-GM film
Thickness of the immobilized therapeutic agent to the COOH plasma polymer is important for
practical medical applications. Depending on the reaction depth, the drug loading capacity and
the kinetics of its release can be different. For example, if immobilization only occurs to the
topmost COOH layer an increase in polymer thickness will not increase the drug loading
capacity. In contrast, if immobilization reaction proceeds over entire depth of the COOH layer,
then by adjusting the polymer layer thickness, it will be possible to control the antibacterial agent
leaching.
The XPS element depth profiles of Si-COOH-GM-Hepa-GM sample are shown in Fig 6a. Sulfur
and nitrogen are distributed inside the entire COOH layer and the content of both elements
13
significantly decreases near the Si wafer surface. The distribution of nitrogen and sulfur is
neither stochastic nor affected by the surface roughness. Note that carbon and oxygen
concentrations are quite stable over the entire COOH layer depth.
By looking closely at carbon components (Fig. 6b), it becomes clear that there is a correlation
between the C-O/C-N ratio and CHx content: while the nitrogen content in the film decreases, the
CHx component increases. The depth profile analysis (Fig. 6c) of the XPS N1s spectra also
shows that the amount of N-containing components decreases with polymer depth. Summarizing
all the XPS profiling data, it can be concluded that both gentamicin and heparin are present
inside the COOH layer and their concentrations decrease with polymer layer depth.




































































































































Fig. 6. XPS depth profiles of the Si-COOH-GM-Hepa-GM sample. Atomic compositions (a),
carbon (b) and nitrogen (c) environments.
3.5 Bactericide release
Figure 7 shows the concentrations of Ag+ ions, gentamicin, and heparin released from different
samples in PBS versus time. In the case of TiCaPCON-Ag film, the concentration of Ag+ ions
rapidly increased to 210 ppb within 12 h and then the release of ions slowed down and almost
completely stopped after 120 h (Fig. 7a). The presence of additional surface layers (COOH, GM,
heparin, and their combinations) retarded Ag+ ion leaching: the thicker the layer, the lower the
ion concentration. Gentamicin can interact with Ag+ ions to form stable Ag/gentamicin
complexes, hereby depleting the concentration of bactericide ions in solution [24]. However, as
follows from a comparison of ion release for the TiCaPCON-Ag-COOH and TiCaPCON-Ag-
GM samples, if such an interaction occurs, it does not significantly affect the Ag+ ion
concentration.
An intensive gentamicin release during 24 h was followed by a slower antibiotic leaching (Fig.
7b). The gentamicin concentration depended on the loading doze (one or two antibiotic layers)
and after 24 h varied from 100 �g/mL (TiCaPCON-Ag) to 275 �g/mL (TiCaPCON-Ag-GM-
Hepa-GM). Interestingly, the presence of Ag accelerated gentamicin leaching. This may be due
to the capture of gentamicin species during intensive Ag+ ion release. Note that both the
accelerated [25,26] and delayed [21] gentamicin release in the presence of silver ions was
reported. Almost all heparin released within 24 h. The existence of top GM layer slightly
retarded heparin leaching (Fig. 7c).
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Fig. 7. Concentration of Ag+ ions (a) and an amount of gentamicin (b) and heparin (c) released in
a PBS versus time.
3.6 Cell proliferation study
The cytocompatibility of all samples were evaluated using the cell proliferation rate analysis
(Fig. 8). Similar to the control (glass and TiCaPCON), the TiCaPCON-Ag and TiCaPCON-
COOH-GM-Hepa samples exhibited a high rate of osteoblastic proliferation indicating their
biocompatibility. Thus Ag+ ions released from the TiCaPCON-Ag film did not affect the
dynamic of bone cell proliferation. The TiCaPCON-COOH sample also demonstrated a positive
dynamics in cell proliferation, albeit slightly delayed relative to control (at day 3). This can be
explained by releasing of carboxylic acid-containing moieties that can induce toxicity [27]. The
TiCaPCON-Ag-COOH-GM and TiCaPCON-COOH-GM samples were also able to maintain a
relatively high level of osteoblastic cell proliferation, even higher compared to TiCaPCON-
COOH. TiCaPCON-COOH-GM-Hepa and TiCaPCON-Ag-COOH-GM-Hepa films showed also
very good cell proliferation rates. Only TiCaPCON-Ag-COOH film exhibited very bad results
(no cell proliferation) due to delamination of the layer during the test (the testing was repeated
three times) and, hence, TiCaPCON-Ag-COOH was toxic for cells, although we confirmed
good stability of TiCaPCON-Ag-COOh in water (see Supporting Information) Most probably the
delamination in this particular case related to the presense of Ag nanoparticles with the size of >
100 nm that decreased the mechanical stability of multilayer samples.Interestingly, the
subsequent samples prepared within the same batch (TiCaPCON-Ag-COOH-GM, TiCaPCON-
Ag-COOH-GM-Hepa, etc.) exhibited very good biocompatibility. Such interesting behavior can
be related to the corssliking effect that is achieved thanks to the reaction between multiple amine
groups from GM and COOH groups in the coating. Indeed, as GM molecules were penetrating
inside the layer, such crosslinking anchor the samples TiCaPCON-Ag_COOH-GM and
following ones.
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The comparison of cell proliferation and bactericide release tests indicates that the concentration
of Ag+ ions in the range of 300-330 ppb (TiCaPCON-Ag sample) did not affect significantly the
dynamics of osteoblastic cell proliferation, being in a good agreement with previous results [21].
Despite the high concentrations of therapeutic agents (100-120 �g/mL for heparin and 250-270
�g/mL for gentamicin), which was reached during immersing the gentamicin and heparin
containing films in PBS, the Ag-free samples were able to maintain high proliferation rate of
osteoblastic cells. In contrast, materials that simultaneously release Ag+ ions and gentamicin may
exhibit increased cytotoxicity [28]. This can be well illustrated with the TiCaPCON-Ag-COOH-
GM sample. Due to extensive Ag+ ions and gentamicin leaching within 72 h (Fig. 7a,b), no
osteoblastic cell proliferation was observed (Fig. 8). However, after 3 days, when the release of
ions and antibiotics almost completely stopped, the number of cells increased sharply.
It is worth to noting, that the combination of Ag nanoparticles and COOH plasma polymer led to
increased toxicity. One possible explanation for this could be the synergistic effect of Ag+ ions
and carboxylic acid-containing moieties. Another factor that should be taken into consideration
is the simultaneous release of Ag+ ions and carboxylic acid -COOH groups, which can result in
increased level of reactive oxygen species (ROS). The reaction of Ag+ ions with molecular
oxygen under aerobic conditions generates superoxide radicals and other ROS [29]. The released
carboxylic acid moieties can undergo oxidation into a pro-oxidant species [30]. Overproduction
of ROS can induce oxidative stress, resulting in cells failing to maintain normal physiological
redox-regulated functions [31] though damaging proteins, nucleic acids, and DNA, cell
signaling, and weakening cell antioxidant defense capacity [32-35]. Finally, Ag+ ions may
induce faster layer degradation due to several possible processes: faster degradation induced by
ROS and/or faster layer dissolution due to formation of soluble complexes between Ag+ and
COOH groups of the plasma layer (some organic acid salts of silver are quite soluble).
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Fig. 8. Osteoblastic cell proliferation on the surface of tested samples without Ag implantation
(a) and with Ag implantation. The statically significance was calculated according to Kruskal-
Wallis criteria: * p<0.01, ** p<0.001, *** p<0.0001.
3.7 Antibacterial activity
The bactericidal activity of samples against antibiotic-resistant bacterial E. coli K261 strain is
shown in Fig. 9. Already after 3 h of incubation, all samples revealed a noticeable antibacterial
effect: 35% (TiCaPCON-Ag), 50% (TiCaPCON-Ag-COOH, TiCaPCON-Ag-COOH-GM, and
TiCaPCON-Ag-COOH-GM-Heap-Gm), 70% (TiCaPCON-COOH and TiCaPCON-COOH-GM-
Hepa), and 90% (TiCaPCON-COOH-GM). After 24 h, all bacterial cells were inactivated on the
surface of TiCaPCON-COOH-GM, TiCaPCON-COOH-GM-Hepa, TiCaPCON-Ag-COOH,
TiCaPCON-Ag-COOH-GM, and TiCaPCON-Ag-COOH-GM-Hepa-GM films. For TiCaPCON-
Ag sample, the bacteria-killing rate was slower, although, after 24 h, 4-log reduction in the
CFU/ml was observed.
The obtained results indicate that two samples, TiCaPCON-Ag and TiCaPCON-COOH-GM-
Hepa, are cytocompatible and show high bactericidal efficiency toward antibiotic-resistant
bacterial E. coli K261 strain. Thus, we demonstrated successful feasibility of two concepts:
adding bactericidal element and grafting therapeutic agent through COOH plasma polymer. In
contrast, the combination of bactericidal Ag+ ions and therapeutic agents did not lead to














































Fig. 9. Antibacterial activity of samples against E. coli K-261 strain.
Conclusions
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1) In this work we showed different concepts for creating antibacterial yet biocompatible
surfaces, namely adding bactericidal element (Ag) and grafting therapeutic agents through
COOH plasma polymer to TiCaPCON film. In addition, two types of gentamicin linkage were
considered: the covalent bonding to the COOH groups of plasma polymer and the ionic
bonding to heparin.
2) The successful immobilization of gentamicin and heparin to the plasma-deposited COOH
layer was confirmed by FTIR and XPS spectroscopies. Both therapeutic agents were present
inside the COOH layer and their concentrations decreased with polymer layer depth.
3) During exposure in phosphate-buffered saline, the samples demonstrated a fast release of Ag+
ions, gentamicin, and heparin within the first 24 h, after which the leaching of heparin stoped,
whereas Ag+ ions and gentamicin released for 120 h. The presence of Ag accelerated
gentamicin leaching.
4) The TiCaPCON-Ag and TiCaPCON-COOH-GM-Hepa films were cytocompatible and
demonstrated superior bactericidal efficiency toward antibiotic-resistant E. coli K261 strain.
The TiCaPCON-COOH and TiCaPCON-Ag-COOH-GM films were also able to maintain a
relatively high level of osteoblastic cell proliferation and significantly reduced a number of
bacterial colony units (more than 1- and 2-log reduction in the CFU/ml after 24 h,
respectively). The surfaces of TiCaPCON-Ag-COOH and TiCaPCON-Ag-COOH-GM-Hepa
films were toxic for osteoblastic cells.
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